The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Eight-Year Follow-Up of Patients With Permanent Vena Cava Filters in the Prevention of Pulmonary Embolism: The PREPIC (Prévention du Risque d’Embolie Pulmonaire par Interruption Cave) Randomized Study
Abstract
Background— In a randomized trial in patients with proximal deep-vein thrombosis, permanent vena cava filters reduced the incidence of pulmonary embolism but increased that of deep-vein thrombosis at 2 years. An 8-year follow-up was performed to assess their very long-term effect. Methods and Results— Four hundred patients with proximal deep-vein thrombosis with or without pulmonary embolism were randomized either to receive or not receive a filter in addition to standard anticoagulant treatment for at least 3 months. Data on vital status, venous thromboembolism, and postthrombotic syndrome were obtained once a year for up to 8 years. All documented events were reviewed blindly by an independent committee. Outcome data were available in 396 patients (99%). Symptomatic pulmonary embolism occurred in 9 patients in the filter group (cumulative rate 6.2%) and 24 patients (15.1%) in the no-filter group ( P =0.008). Deep-vein thrombosis occurred in 57 patients (35.7%) in the filter group and 41 (27.5%) in the no-filter group ( P =0.042). Postthrombotic syndrome was observed in 109 (70.3%) and 107 (69.7%) patients in the filter and no-filter groups, respectively. At 8 years, 201 (50.3%) patients had died (103 and 98 patients in the filter and no-filter groups, respectively). Conclusions At 8 years, vena cava filters reduced the risk of pulmonary embolism but increased that of deep-vein thrombosis and had no effect on survival. Although their use may be beneficial in patients at high risk of pulmonary embolism, systematic use in the general population with venous thromboembolism is not recommended.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Long-Term Clinical Course of Acute Deep Venous Thrombosis
Prandoni, P., Lensing, A. W. A., Cogo, A., Cuppini, S., Villalta, S., Carta, M., Cattelan, A. M., Polistena, P., Bernardi, E., & Prins, M. H. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-1-199607010-00001 · Cited by 2,109
Incidence of Chronic Thromboembolic Pulmonary Hypertension after Pulmonary Embolism
Pengo, V., Lensing, A. W. A., Prins, M. H., Marchiori, A., Davidson, B. L., Tiozzo, F., Albanese, P., Biasiolo, A., Pegoraro, C., Iliceto, S., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032274 · Cited by 1,828
Decousus, H., Leizorovicz, A., Parent, F., Page, Y., Tardy, B., Girard, P., Laporte, S., Faivre, R., Charbonnier, B., Barral, F.-G., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802123380701 · Cited by 1,702
Anderson, F. A. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.1991.00400050081016 · Cited by 1,669
Heit, J. A., Mohr, D. N., Silverstein, M. D., Petterson, T. M., O'Fallon, W. M., & Melton, L. J. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.6.761 · Cited by 1,352
Antithrombotic Therapy for Venous Thromboembolic Disease
Büller, H. R., Agnelli, G., Hull, R. D., Hyers, T. M., Prins, M. H., & Raskob, G. E. (2004) · Chest · doi:10.1378/chest.126.3_suppl.401s · Cited by 1,249
Kearon, C., Gent, M., Hirsh, J., Weitz, J., Kovacs, M. J., Anderson, D. R., Turpie, A. G., Green, D., Ginsberg, J. S., Wells, P., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903253401201 · Cited by 1,072
(2003) · New England Journal of Medicine · doi:10.1056/nejmoa035451 · Cited by 887
Brandjes, D. P., Büller, H. R., Heijboer, H., Huisman, M. V., de Rijk, M., Jagt, H., & ten Cate, J. W. (1997) · The Lancet · doi:10.1016/s0140-6736(96)12215-7 · Cited by 873
Long-Term, Low-Intensity Warfarin Therapy for the Prevention of Recurrent Venous Thromboembolism
Ridker, P. M., Goldhaber, S. Z., Danielson, E., Rosenberg, Y., Eby, C. S., Deitcher, S. R., Cushman, M., Moll, S., Kessler, C. M., Elliott, C. G., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035029 · Cited by 808
Kearon, C., Ginsberg, J. S., Kovacs, M. J., Anderson, D. R., Wells, P., Julian, J. A., MacKinnon, B., Weitz, J. I., Crowther, M. A., Dolan, S., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035422 · Cited by 751
Prandoni, P., Lensing, A. W. A., Prins, M. H., Frulla, M., Marchiori, A., Bernardi, E., Tormene, D., Mosena, L., Pagnan, A., & Girolami, A. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-4-200408170-00004 · Cited by 659
Risk of Fatal Pulmonary Embolism in Patients With Treated Venous Thromboembolism
Douketis, J. D. (1998) · JAMA · doi:10.1001/jama.279.6.458 · Cited by 617
Büller, H. R., Davidson, B. L., Decousus, H., Gallus, A., Gent, M., Piovella, F., Prins, M. H., Raskob, G., Segers, A. E. M., Cariou, R., et al. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-11-200406010-00007 · Cited by 617
Heit, J. A., Silverstein, M. D., Mohr, D. N., Petterson, T. M., O'Fallon, W. M., & Melton, L. J. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.5.445 · Cited by 594
Three Months versus One Year of Oral Anticoagulant Therapy for Idiopathic Deep Venous Thrombosis
Agnelli, G., Prandoni, P., Santamaria, M. G., Bagatella, P., Iorio, A., Bazzan, M., Moia, M., Guazzaloca, G., Bertoldi, A., Tomasi, C., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107193450302 · Cited by 591
Recurrent Venous Thromboembolism After Deep Vein Thrombosis: Incidence and Risk Factors
Hansson, P.-O., Sörbo, J., & Eriksson, H. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.6.769 · Cited by 590
The Epidemiology of Venous Thromboembolism in the Community
Mohr, D., Petterson, T., Lohse, C., O’Fallon, W. M., Melton, L. J., Heit, J., & Silverstein, M. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616243 · Cited by 571
A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis
Goldhaber, S. Z., & Tapson, V. F. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2003.09.057 · Cited by 480
Brandjes, D. P. M., Heijboer, H., Büller, H. R., de Rijk, M., Jagt, H., & ten Cate, J. W. (1992) · New England Journal of Medicine · doi:10.1056/nejm199211193272103 · Cited by 480
Secondary Prevention of Venous Thromboembolism with the Oral Direct Thrombin Inhibitor Ximelagatran
Schulman, S., Wåhlander, K., Lundström, T., Clason, S. B., & Eriksson, H. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030104 · Cited by 454
Musset, D., Parent, F., Meyer, G., Maître, S., Girard, P., Leroyer, C., Revel, M.-P., Carette, M.-F., Laurent, M., Charbonnier, B., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11914-3 · Cited by 402
Vena caval filters: a comprehensive review
Streiff, M. B. (2000) · Blood · doi:10.1182/blood.v95.12.3669 · Cited by 370
Goldhaber, S. Z. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16004-2 · Cited by 348
Long-term Outcomes of Deep-Vein Thrombosis
Beyth, R. J. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.155.10.1031 · Cited by 231
White, R. H., Zhou, H., Kim, J., & Romano, P. S. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.13.2033 · Cited by 195
Symptomatic Pulmonary Embolism and the Risk of Recurrent Venous Thromboembolism
Eichinger, S., Weltermann, A., Minar, E., Stain, M., Schönauer, V., Schneider, B., & Kyrle, P. A. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.1.92 · Cited by 168
Medical Literature and Vena Cava Filters
Girard, P., Stern, J., & Parent, F. (2002) · CHEST Journal · doi:10.1378/chest.122.3.963 · Cited by 110
Recurrence of pulmonary embolism during anticoagulant treatment: a prospective study.
Girard, P., Mathieu, M., Simonneau, G., et al. (1987) · Thorax · doi:10.1136/thx.42.7.481 · Cited by 48
Spurious scintiphotographic recurrence of pulmonary emboli
Moser, K. Μ., Longo, A. M., Ashburn, W. L., et al. (1973) · The American Journal of Medicine · doi:10.1016/0002-9343(73)90200-3 · Cited by 35
Laporte, S., Tardy, B., Quenet, S., Buchmüller-Cordier, A., Chabaud, S., Epinat, M., Decousus, H., & Mismetti, P. (2003) · PubMed · Cited by 17
Cited by
Kearon (2012) · doi:10.1378/chest.11-2301 · Cited by 6,119
Konstantinides, S. V., Meyer, G., Becattini, C., Bueno, H., Geersing, G.-J., Harjola, V.-P., Huisman, M. V., Humbert, M., Jennings, C. S., Jiménez, D., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz405 · Cited by 4,916
Antithrombotic Therapy for VTE Disease
Kearon, C., Akl, E. A., Ornelas, J., Blaivas, A., Jimenez, D., Bounameaux, H., Huisman, M., King, C. S., Morris, T. A., Sood, N., et al. (2016) · Chest · doi:10.1016/j.chest.2015.11.026 · Cited by 4,830
2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism
Authors/Task Force Members, Konstantinides, S. V., Torbicki, A., Agnelli, G., Danchin, N., Fitzmaurice, D., Galiè, N., Gibbs, J. S. R., Huisman, M. V., Humbert, M., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu283 · Cited by 3,128
Guidelines on the diagnosis and management of acute pulmonary embolism
Authors/Task Force Members, Torbicki, A., Perrier, A., Konstantinides, S., Agnelli, G., Galiè, N., Pruszczyk, P., Bengel, F., Brady, A. J. B., Ferreira, D., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn310 · Cited by 2,826
Metadata
- Authors
- The PREPIC Study Group
- Venue
- Circulation
- Published
- 2005-07-19
- Volume
- 112
- Issue
- 3
- Pages
- 416-422
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W4255679514
- Cited by
- 931
- References
- 32
- FWCI
- 24.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.